Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | BCL9 | O00512 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 2/20 | 0.48 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17513779 | 0.92 | GAA (0.53) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL2721445 | 0.87 | GAA (0.54) | ELANEGAABCL9CTNNB1HTR2A | |
| Nitrobenzene SCHEMBL7359201 | 0.86 | SMN1; SMN2 (0.50) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL763093 | 0.86 | BCL9 (0.54) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL343250 | 0.84 | GAA (0.51) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL6348996 | 0.84 | BCL9 (0.56) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL903436 | 0.84 | BCL9 (0.52) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL6359040 | 0.84 | BCL9 (0.56) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL5487025 | 0.84 | GAA (0.51) | ELANEGAABCL9CTNNB1HTR2A | |
| SCHEMBL7412943 | 0.84 | GAA (0.51) | ELANEGAABCL9CTNNB1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116462643-A | Synthetic method of deuterium or tritium marked docetaxel | 无锡贝塔医药科技有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4619048-A1 | CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS | Ustav Organicke Chemie a Biochemie AV CR v.v.i. (CZ) | 2025-09-24 | — | — | EP | disclosed |
| CN-116462643-B | Synthetic method of deuterium-labeled docetaxel | 无锡贝塔医药科技有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-116462643-B | Synthetic method of deuterium-labeled docetaxel | 无锡贝塔医药科技有限公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2024226691-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024120557-A1 | CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS | Ustav Organicke Chemie A Biochemie AV CR v.v.i. (CZ) | 2024-06-13 | — | — | WO | disclosed |
| EP-4382136-A1 | CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2024-06-12 | — | — | EP | disclosed |
| CN-116462643-A | Synthetic method of deuterium or tritium marked docetaxel | 无锡贝塔医药科技有限公司 | 2023-07-21 | — | — | CN | disclosed |
| EP-0773950-A1 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS, INC. (US) | 1997-05-21 | — | — | EP | disclosed |
| US-5539082-A | Peptide nucleic acids | NIELSEN PETER E (DK) | 1996-07-23 | — | — | US | disclosed |
| WO-1996002558-A1 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-02-01 | — | — | WO | disclosed |
| EP-0602069-A4 | RETROVIRAL PROTEASE INHIBITORS. | SMITHKLINE BEECHAM CORP (US) | 1995-05-03 | — | — | EP | disclosed |
| EP-0602069-A1 | RETROVIRAL PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-06-22 | — | — | EP | disclosed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | disclosed |
| EP-0095294-A1 | Deoxyuridine compounds, methods for preparing them and their use in medicine | BEECHAM GROUP PLC (GB) | 1983-11-30 | — | — | EP | disclosed |
| US-4145337-A | SOMATOSTATINS, ANTISECRETORY | HOFFMANN-LA ROCHE INC. (US) | 1979-03-20 | — | — | US | disclosed |
| US-4110534-A | PROCESS FOR THE PREPARATION OF 3-VINYL AND SUBSTITUTED VINYL CEPHALOSPORINS | GLAXO LABORATORIES LIMITED (GB) | 1978-08-29 | — | — | US | disclosed |
| US-4107431-A | ANTIBIOTICS | GLAXO LABORATORIES LIMITED (GB) | 1978-08-15 | — | — | US | disclosed |